Wednesday, 18 May 2016

Global Biologic Therapeutics Market to grow at a CAGR of 8.26% over the period 2014-2019 : Hexa Reports

Biologic therapeutics include virus, therapeutic serums, toxins, allergenic products, antitoxin, blood components or derivatives, vaccines, blood, and proteins (except any chemically synthesized polypeptide). They also include analogous products, arsphenamine, or derivatives of arsphenamine (or any other trivalent organic arsenic compound) for the prevention, treatment, or cure of a disease. The differences between the biologics and small molecules include the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics have a higher molecular weight and a complex molecular structure. They are usually derived from living entities, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures (thermolabile) and light. 

 Request A Sample copy of This Report @

Covered in this report
This report covers the present scenario and the growth prospects of the global biologic therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics).

Other protein therapeutics covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

Pharmaceutical Market Research Reports

Key regions

Key vendors
 F. Hoffmann-La Roche
 Novo Nordisk

Other prominent vendors
 Bavarian Nordic
 Baxter International
 Beijing Minhai Biotechnology
 Bharat Biotech
 Bharat Immunologicals and Biologicals
 Bio Med Pvt.
 Bristol-Myers Squibb
 Diamyd Medical
 Dynavax Technologies
 Eli Lilly
 Generex Biotechnology
 Hualan Biological Engineering
 Imunoloski Zavod
 Indian Immunologicals
 JN International Medical
 LG Life Sciences
 Mitsubishi Tanabe Pharma
 Nuron Biotech
 Osiris Therapeutics
 Protein Sciences
 Serum Institute of India
 Shenzhen Kangtai Biological Products
 Sinovac Biotech
 Vacunas Finlay
 Zydus Cadila 

Market driver
 Reimbursement support for biologics
 For a full, detailed list, view our report

Market challenge
 High cost of therapy
 For a full, detailed list, view our report

Market trend
 Emergence of targeted and combination therapies
 For a full, detailed list, view our report

Key question answered in this report
 What will the market size be in 2019 and what will the growth rate be?
 What are the key market trends?
 What is driving this market?
 What are the challenges to market growth?
 Who are the key vendors in this market space?
 What are the market opportunities and threats faced by the key vendors?
 What are the strengths and weaknesses of the key vendors?   
Visit Our Website:

Contact Information:

Ryan Shaw

Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number

No comments:

Post a Comment